Goldman Sachs reiterated its Neutral rating on Omnicare OCR. At the same time, Goldman left its price target on the company's stock unchanged at $32. On Tuesday, Omnicare lost 0.12% of its value to finish the day at $32.13.
Market News and Data brought to you by Benzinga APIs© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in
